Cargando…
The mechanism of PI3Kα activation at the atomic level
PI3K lipid kinases phosphorylate PIP(2) to PIP(3) in the PI3K/Akt/mTOR pathway to regulate cellular processes. They are frequently mutated in cancer. Here we determine the PI3Kα activation mechanism at the atomic level. Unlike protein kinases where the substrate abuts the ATP, crystal structures ind...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430085/ https://www.ncbi.nlm.nih.gov/pubmed/30996962 http://dx.doi.org/10.1039/c8sc04498h |
_version_ | 1783405726955208704 |
---|---|
author | Zhang, Mingzhen Jang, Hyunbum Nussinov, Ruth |
author_facet | Zhang, Mingzhen Jang, Hyunbum Nussinov, Ruth |
author_sort | Zhang, Mingzhen |
collection | PubMed |
description | PI3K lipid kinases phosphorylate PIP(2) to PIP(3) in the PI3K/Akt/mTOR pathway to regulate cellular processes. They are frequently mutated in cancer. Here we determine the PI3Kα activation mechanism at the atomic level. Unlike protein kinases where the substrate abuts the ATP, crystal structures indicate that in PI3Kα, the distance between the γ phosphate of the ATP and the PIP(2) lipid substrate is over 6 Å, much too far for the phosphoryl transfer, raising the question of how catalysis is executed. PI3Kα has two subunits, the catalytic p110α and the regulatory p85α. Our simulations show that release of the autoinhibition exerted by the nSH2 domain of the p85α triggers significant conformational change in p110α, leading to the exposure of the kinase domain for membrane interaction. Structural rearrangement in the C-lobe of the kinase domain reduces the distance between the ATP γ-phosphate and the substrate, offering an explanation as to how phosphoryl transfer is executed. An alternative mechanism may involve ATP relocation. This mechanism not only explains how oncogenic mutations promote PI3Kα activation by facilitating nSH2 release, or nSH2-release-induced, allosteric motions; it also offers an innovative, PI3K isoform-specific drug discovery principle. Rather than competing with nanomolar range ATP in the ATP-binding pocket and contending with ATP pocket conservation and massive binding targets, this mechanism suggests blocking the PI3Kα sequence-specific cavity between the ATP-binding pocket and the substrate binding site. Targeting isoform-specific residues in the cavity may prevent PIP(2) phosphorylation. |
format | Online Article Text |
id | pubmed-6430085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-64300852019-04-17 The mechanism of PI3Kα activation at the atomic level Zhang, Mingzhen Jang, Hyunbum Nussinov, Ruth Chem Sci Chemistry PI3K lipid kinases phosphorylate PIP(2) to PIP(3) in the PI3K/Akt/mTOR pathway to regulate cellular processes. They are frequently mutated in cancer. Here we determine the PI3Kα activation mechanism at the atomic level. Unlike protein kinases where the substrate abuts the ATP, crystal structures indicate that in PI3Kα, the distance between the γ phosphate of the ATP and the PIP(2) lipid substrate is over 6 Å, much too far for the phosphoryl transfer, raising the question of how catalysis is executed. PI3Kα has two subunits, the catalytic p110α and the regulatory p85α. Our simulations show that release of the autoinhibition exerted by the nSH2 domain of the p85α triggers significant conformational change in p110α, leading to the exposure of the kinase domain for membrane interaction. Structural rearrangement in the C-lobe of the kinase domain reduces the distance between the ATP γ-phosphate and the substrate, offering an explanation as to how phosphoryl transfer is executed. An alternative mechanism may involve ATP relocation. This mechanism not only explains how oncogenic mutations promote PI3Kα activation by facilitating nSH2 release, or nSH2-release-induced, allosteric motions; it also offers an innovative, PI3K isoform-specific drug discovery principle. Rather than competing with nanomolar range ATP in the ATP-binding pocket and contending with ATP pocket conservation and massive binding targets, this mechanism suggests blocking the PI3Kα sequence-specific cavity between the ATP-binding pocket and the substrate binding site. Targeting isoform-specific residues in the cavity may prevent PIP(2) phosphorylation. Royal Society of Chemistry 2019-02-20 /pmc/articles/PMC6430085/ /pubmed/30996962 http://dx.doi.org/10.1039/c8sc04498h Text en This journal is © The Royal Society of Chemistry 2019 http://creativecommons.org/licenses/by-nc/3.0/ This article is freely available. This article is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported Licence (CC BY-NC 3.0) |
spellingShingle | Chemistry Zhang, Mingzhen Jang, Hyunbum Nussinov, Ruth The mechanism of PI3Kα activation at the atomic level |
title | The mechanism of PI3Kα activation at the atomic level
|
title_full | The mechanism of PI3Kα activation at the atomic level
|
title_fullStr | The mechanism of PI3Kα activation at the atomic level
|
title_full_unstemmed | The mechanism of PI3Kα activation at the atomic level
|
title_short | The mechanism of PI3Kα activation at the atomic level
|
title_sort | mechanism of pi3kα activation at the atomic level |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430085/ https://www.ncbi.nlm.nih.gov/pubmed/30996962 http://dx.doi.org/10.1039/c8sc04498h |
work_keys_str_mv | AT zhangmingzhen themechanismofpi3kaactivationattheatomiclevel AT janghyunbum themechanismofpi3kaactivationattheatomiclevel AT nussinovruth themechanismofpi3kaactivationattheatomiclevel AT zhangmingzhen mechanismofpi3kaactivationattheatomiclevel AT janghyunbum mechanismofpi3kaactivationattheatomiclevel AT nussinovruth mechanismofpi3kaactivationattheatomiclevel |